Arrowstreet Capital
PRVA icon

Arrowstreet Capital’s Privia Health PRVA Stock Holding History

Arrowstreet Capital’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$727K Buy
+28,247
New +$654K ﹤0.01% 1699

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Arrowstreet Capital's PRVA Position: Q2 2026 in Review

Arrowstreet Capital opened a new position in Privia Health (PRVA) in Q2 2026: 28,247 shares worth $727K. The stake represents ﹤0.01% of the portfolio and ranks #1699 among its holdings.

301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Arrowstreet Capital held 28,247 shares of Privia Health worth $727K as of Q2 2026.
  • Privia Health was a new Arrowstreet Capital position in Q2 2026.
  • Privia Health made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1699 holding.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.